UB Paderborn / Katalog / Suche / in CDI

A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II

Molecular therapy, 2018-05, Vol.26 (5), p.1366-1374

2018

Link zum Volltext

Verfügbarkeit prüfen

Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method

Endocrine Journal, 2012, Vol.59(9), pp.771-780

2012

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS

Molecular genetics and metabolism, 2018-09, Vol.125 (1-2), p.53-58

2018

Link zum Volltext

Verfügbarkeit prüfen

Continuing efforts to standardize measured serum growth hormone values in Japan

Endocrine Journal, 2016, Vol.63(10), pp.933-936

2016

Link zum Volltext

Verfügbarkeit prüfen

Frequencies of spontaneous breast development and spontaneous menarche in Turner syndrome in Japan

Clinical Pediatric Endocrinology, 2015, Vol.24(4), pp.167-173

2015

Link zum Volltext

Verfügbarkeit prüfen

Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma

The Journal of pathology, 2004-07, Vol.203 (3), p.814-821

2004

Link zum Volltext

Verfügbarkeit prüfen

Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial

Molecular therapy, 2019-02, Vol.27 (2), p.456-464

2019

Link zum Volltext

Verfügbarkeit prüfen

Turner Syndrome and Xp Deletions: Clinical and Molecular Studies in 47 Patients

The journal of clinical endocrinology and metabolism, 2001-11, Vol.86 (11), p.5498-5508

2001

Link zum Volltext

Verfügbarkeit prüfen

A nationwide attempt to standardize growth hormone assays

Hormone research, 2005-01, Vol.64 Suppl 2, p.6-11

2005

Link zum Volltext

Verfügbarkeit prüfen

Recent Status in the Occurrence of Leukemia in Growth Hormone-Treated Patients in Japan

The journal of clinical endocrinology and metabolism, 1999-06, Vol.84 (6), p.1961-1965

1999

Link zum Volltext

Verfügbarkeit prüfen

Congenital absence of the portal vein and role of liver transplantation in children

Journal of pediatric surgery, 2001-07, Vol.36 (7), p.1026-1031

2001

Link zum Volltext

Verfügbarkeit prüfen

Gonadal Suppression Therapy

Clinical Pediatric Endocrinology, 2005, Vol.14(Supplement24), pp.S24_1-S24_5

Tachibana, Katsuhiko

2005

Link zum Volltext

Verfügbarkeit prüfen

Frequencies of spontaneous breast development and spontaneous menarche in Turner syndrome in Japan

Clinical Pediatric Endocrinology, 2015-10, Vol.24 (4), p.167-173

2015

Link zum Volltext

Verfügbarkeit prüfen

Favorable Impact of Growth Hormone Treatment on Cholesterol Levels in Turner Syndrome

Clinical Pediatric Endocrinology, 2012, Vol.21(2), pp.29-34

2012

Link zum Volltext

Verfügbarkeit prüfen

Molecular Analysis of the CLCNKB Gene in Japanese Patients with Classic Bartter Syndrome

Endocrine Journal, 2006, Vol.53(5), pp.647-652

2006

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Quality of Life in Children with GH Deficiency and Idiopathic Short Stature Using the Child Behavior Checklist

Clinical Pediatric Endocrinology, 2009, Vol.18(1), pp.15-22

2009

Link zum Volltext

Verfügbarkeit prüfen

Adult Heights of 258 Girls with Turner Syndrome on Low Dose of Growth Hormone Therapy in Japan

Clinical Pediatric Endocrinology, 2010, Vol.19(3), pp.63-68

2010

Link zum Volltext

Verfügbarkeit prüfen

Abnormal steroidogenesis in three patients with Antley-Bixler syndrome: Apparent decreased activity of 17α-hydroxylase, 17,20-lyase and 21-hydroxylase

Pediatrics international, 2004-10, Vol.46 (5), p.583-589

2004

Link zum Volltext

Verfügbarkeit prüfen

378. Improved Transduction of Canine X-Linked Muscular Dystrophy with rAAV9-Microdystrophin by Introducing Immune Tolerance

Molecular therapy, 2016-05, Vol.24, p.S150-S151

2016

Link zum Volltext

Verfügbarkeit prüfen

238. Cell Therapeutic Approach Using Dental Pulp Stromal Cells for Duchenne Muscular Dystrophy

Molecular therapy, 2016-05, Vol.24, p.S93-S93

2016

Link zum Volltext

Verfügbarkeit prüfen

Standardization of Blood Growth Hormone Levels Measured by Different Kits Using a Linear Structural Relationship

Clinical Pediatric Endocrinology, 2006, Vol.15(3), pp.79-84

2006

Link zum Volltext

Verfügbarkeit prüfen

Blood-brain barrier-penetrating iduronate-2-sulfatase reduces brain glycosaminoglycans in mouse model of mucopolysaccharidosis type II

Molecular genetics and metabolism, 2018-02, Vol.123 (2), p.S134-S134

2018

Link zum Volltext

Verfügbarkeit prüfen

400. Improved Transduction of Canine X-Linked Muscular Dystrophy With rAAV9-Microdystrophin By Using MSCs Pretreatment

Molecular therapy, 2015-05, Vol.23, p.S158-S159

2015

Link zum Volltext

Verfügbarkeit prüfen

Studies of Very Severe Short Stature with Severe GH Deficiency: From the Data Registered with the Foundation for Growth Science

Endocrine Journal, 2005, Vol.52(1), pp.37-43

2005

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II

Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method

Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS

Continuing efforts to standardize measured serum growth hormone values in Japan

Frequencies of spontaneous breast development and spontaneous menarche in Turner syndrome in Japan

Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma

Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial

Turner Syndrome and Xp Deletions: Clinical and Molecular Studies in 47 Patients

A nationwide attempt to standardize growth hormone assays

Recent Status in the Occurrence of Leukemia in Growth Hormone-Treated Patients in Japan

Congenital absence of the portal vein and role of liver transplantation in children

Gonadal Suppression Therapy

Frequencies of spontaneous breast development and spontaneous menarche in Turner syndrome in Japan

Favorable Impact of Growth Hormone Treatment on Cholesterol Levels in Turner Syndrome

Molecular Analysis of the CLCNKB Gene in Japanese Patients with Classic Bartter Syndrome

Evaluation of Quality of Life in Children with GH Deficiency and Idiopathic Short Stature Using the Child Behavior Checklist

Adult Heights of 258 Girls with Turner Syndrome on Low Dose of Growth Hormone Therapy in Japan

Abnormal steroidogenesis in three patients with Antley-Bixler syndrome: Apparent decreased activity of 17α-hydroxylase, 17,20-lyase and 21-hydroxylase

378. Improved Transduction of Canine X-Linked Muscular Dystrophy with rAAV9-Microdystrophin by Introducing Immune Tolerance

238. Cell Therapeutic Approach Using Dental Pulp Stromal Cells for Duchenne Muscular Dystrophy

Standardization of Blood Growth Hormone Levels Measured by Different Kits Using a Linear Structural Relationship

Clinical Characteristics, Etiologies and Pathophysiology of Patients with Severe Short Stature with Severe GH Deficiency: Questionnaire Study on the Data Registered with the Foundation for Growth Science, Japan

Blood-brain barrier-penetrating iduronate-2-sulfatase reduces brain glycosaminoglycans in mouse model of mucopolysaccharidosis type II

400. Improved Transduction of Canine X-Linked Muscular Dystrophy With rAAV9-Microdystrophin By Using MSCs Pretreatment

Studies of Very Severe Short Stature with Severe GH Deficiency: From the Data Registered with the Foundation for Growth Science

Suchergebnisse filtern